257 related articles for article (PubMed ID: 29730954)
1. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Characterization of the Extracellular Matrix of Human Uterine Fibroids.
Jamaluddin MFB; Nahar P; Tanwar PS
Endocrinology; 2018 Jul; 159(7):2656-2669. PubMed ID: 29788081
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
[TBL] [Abstract][Full Text] [Related]
6. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
[TBL] [Abstract][Full Text] [Related]
7. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
[TBL] [Abstract][Full Text] [Related]
8. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
[TBL] [Abstract][Full Text] [Related]
9. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome.
Barron L; Khadka S; Schenken R; He L; Blenis J; Blagg J; Chen SF; Tsai KL; Boyer TG
F S Sci; 2021 Nov; 2(4):383-395. PubMed ID: 35559861
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
[TBL] [Abstract][Full Text] [Related]
12. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
[TBL] [Abstract][Full Text] [Related]
13. Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy.
Di Tommaso S; Massari S; Malvasi A; Vergara D; Maffia M; Greco M; Tinelli A
Expert Opin Ther Targets; 2015 Jan; 19(1):7-12. PubMed ID: 25363374
[TBL] [Abstract][Full Text] [Related]
14. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
Croce S; Chibon F
Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
[TBL] [Abstract][Full Text] [Related]
15. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
McGuire MM; Yatsenko A; Hoffner L; Jones M; Surti U; Rajkovic A
PLoS One; 2012; 7(3):e33251. PubMed ID: 22428002
[TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Biol Reprod; 2013 Dec; 89(6):150. PubMed ID: 24174578
[TBL] [Abstract][Full Text] [Related]
19. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
20. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
